Evidence map›Paper›PMID 28506643›Full record

ArticleExperimental eye research2017

Epithelial basement membrane injury and regeneration modulates corneal fibrosis after pseudomonas corneal ulcers in rabbits.

Gustavo K Marino, Marcony R Santhiago, Abirami Santhanam, Luciana Lassance, Shanmugapriya Thangavadivel, Carla S Medeiros, Karthikeyan Bose, Kwai Ping Tam, Steven E Wilson

Open access · greenAbstract read
In one paragraph

Article in Experimental eye research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 1 pooled it
5.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 1 synthesis or guideline pooled it, 63 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Topical Losartan: Practical Guidance for Clinical Trials in the Prevention and Treatment of Corneal Scarring Fibrosis and Other Eye Diseases and Disorders.Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics · 2023
    Review
  9. Article
  10. Review
  11. Magic Bullets: The Coming Age of Meaningful Pharmacological Control of the Corneal Responses to Injury and Disease.Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics · 2022
    Article
  12. Article
  13. Article
  14. Extracellular Vesicles in Corneal Fibrosis/Scarring.International journal of molecular sciences · 2022
    Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Gustavo K MarinoCole Eye Institute, Cleveland Clinic, Cleveland, OH, United States; University of São Paulo, São Paulo, Brazil.
Marcony R SanthiagoUniversity of São Paulo, São Paulo, Brazil.
Abirami SanthanamCole Eye Institute, Cleveland Clinic, Cleveland, OH, United States.
Luciana LassanceCole Eye Institute, Cleveland Clinic, Cleveland, OH, United States.
Shanmugapriya ThangavadivelCole Eye Institute, Cleveland Clinic, Cleveland, OH, United States.
Carla S MedeirosCole Eye Institute, Cleveland Clinic, Cleveland, OH, United States.
Karthikeyan BoseCole Eye Institute, Cleveland Clinic, Cleveland, OH, United States.
Kwai Ping TamCole Eye Institute, Cleveland Clinic, Cleveland, OH, United States.
Steven E WilsonCole Eye Institute, Cleveland Clinic, Cleveland, OH, United States. Electronic address: wilsons4@ccf.org.
Cleveland Clinic · USUniversidade de São Paulo · BR

Funding

Vision Research CoreP30EY001730 · NEI · UNIVERSITY OF WASHINGTON · PI MAUREEN E NEITZ · 1985 to 2026
$23.5M
RESOURCE/SERVICE CORE C - MOLECULAR INFORMATICS MODULEP30EY025585 · NEI · CLEVELAND CLINIC LERNER COM-CWRU · PI BELA ANAND-APTE · 2016 to 2026
$7.7M
Corneal Epithelial Growth Factors and ReceptorsR01EY010056 · NEI · UNIVERSITY OF WASHINGTON · PI WILSON, STEVEN EUGENE · 1994 to 2020
$7.4M
Cytoskeletal Keratins in Epithelial Immunity to Bacterial KeratitisR01EY023000 · NEI · UNIVERSITY OF CALIFORNIA BERKELEY · PI TAM, K. P. CONNIE · 2013 to 2017
$1.8M
Transmission Electron MicroscopeS10RR031536 · NCRR · CLEVELAND CLINIC LERNER COM-CWRU · PI DRAZBA, JUDY · 2011 to 2011
$518k
NCRR NIH HHS S10 RR031536NEI NIH HHS P30 EY001730NEI NIH HHS P30 EY025585NEI NIH HHS R01 EY010056NEI NIH HHS R01 EY023000
6 · The paper itself

Abstract

The purpose of this study was to investigate whether myofibroblast-related fibrosis (scarring) after microbial keratitis was modulated by the epithelial basement membrane (EBM) injury and regeneration. Rabbits were infected with Pseudomonas aeruginosa after epithelial scrape injury and the resultant severe keratitis was treated with topical tobramycin. Corneas were analyzed from one to four months after keratitis with slit lamp photos, immunohistochemistry for alpha-smooth muscle actin (α-SMA) and monocyte lineage marker CD11b, and transmission electron microscopy. At one month after keratitis, corneas had no detectible EBM lamina lucida or lamina densa, and the central stroma was packed with myofibroblasts that in some eyes extended to the posterior corneal surface with damage to Descemet's membrane and the endothelium. At one month, a nest of stromal cells in the midst of the SMA + myofibroblasts in the stroma that were CD11b+ may be fibrocyte precursors to myofibroblasts. At two to four months after keratitis, the EBM fully-regenerated and myofibroblasts disappeared from the anterior 60-90% of the stroma of all corneas, except for one four-month post-keratitis cornea where anterior myofibroblasts were still present in one localized pocket in the cornea. The organization of the stromal extracellular matrix also became less disorganized from two to four months after keratitis but remained abnormal compared to controls at the last time point. Myofibroblasts persisted in the posterior 10%-20% of posterior stroma even at four months after keratitis in the central cornea where Descemet's membrane and the endothelium were damaged. This study suggests that the EBM has a critical role in modulating myofibroblast development and fibrosis after keratitis-similar to the role of EBM in fibrosis after photorefractive keratectomy. Damage to EBM likely allows epithelium-derived transforming growth factor beta (TGFβ) to penetrate the stroma and drive development and persistence of myofibroblasts. Eventual repair of EBM leads to myofibroblast apoptosis when the cells are deprived of requisite TGFβ to maintain viability. The endothelium and Descemet's membrane may serve a similar function modulating TGFβ penetration into the posterior stroma-with the source of TGFβ likely being the aqueous humor.

Indexed as

ActinsAnimalsBiomarkersCD11b AntigenCorneal InjuriesCorneal StromaCorneal UlcerDescemet MembraneDisease Models, AnimalEpithelium, CornealEye Infections, BacterialFemaleFibrosisImmunohistochemistryMyofibroblastsPseudomonas InfectionsActinsBiomarkersCD11b AntigenBacterial keratitisCorneal ulcerDescemet's membraneEpithelial basement membraneFibrosisMyofibroblastsScarring

Identifiers

PMID28506643
PMCPMC5554721
OpenAlexW2613217071

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.